HYPERION DEFI, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
HYPERION DEFI, INC. (HYPD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.62 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.62M shares, a 94.83% decline year-over-year.
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 33.28M shares, a 1871.97% increase year-over-year.
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 12.66M shares, a 2542.44% increase year-over-year.
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 50.72M shares.
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 51.77M shares, a 3982.76% increase from fiscal 2024.
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.27M shares, a 443.39% increase from fiscal 2023.
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 233.33K shares, a 98.00% decline from fiscal 2022.
- HYPERION DEFI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 11.64M shares, a 106.52% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.62M shares 10-Q · filed 2026-08-13 | 2.60M shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 33.28M shares 10-Q · filed 2026-05-15 | ||||||||
| 2025-12-31 | 51.77M shares 10-K · filed 2026-03-30 | ||||||||
| 2025-09-30 | 12.66M shares 10-Q · filed 2025-11-14 | 51.85M shares 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | 50.72M shares 10-Q · filed 2026-08-13 | 50.72M shares 10-Q · filed 2026-08-13 | 34.41M shares 10-Q · filed 2025-08-13 | ||||||
| 2025-03-31 | 1.69M shares 10-Q · filed 2026-05-15 | ||||||||
| 2024-12-31 | 1.27M shares 10-K · filed 2026-03-30 | ||||||||
| 2024-09-30 | 479.24K shares 10-Q · filed 2025-11-14 | 479.24K shares 10-Q · filed 2025-11-14 | 38.34M shares 10-Q · filed 2024-11-12 | ||||||
| 2024-06-30 | 252.78K shares 10-Q · filed 2025-08-13 | 20.22M shares 10-Q · filed 2024-08-14 | |||||||
| 2024-03-31 | 242.29K shares 10-Q · filed 2025-05-19 | 19.38M shares 10-Q · filed 2024-05-15 | |||||||
| 2023-12-31 | 233.33K shares 10-K · filed 2025-04-15 | 18.67M shares 10-K · filed 2024-03-18 | |||||||
| 2023-09-30 | 18.56M shares 10-Q · filed 2024-11-12 | ||||||||
| 2023-06-30 | 13.69M shares 10-Q · filed 2024-08-14 | ||||||||
| 2023-03-31 | 14.03M shares 10-Q · filed 2024-05-15 | 11.70M shares 10-Q · filed 2023-05-12 | |||||||
| 2022-12-31 | 11.64M shares 10-K · filed 2024-03-18 | ||||||||
| 2022-09-30 | 11.75M shares 10-Q · filed 2023-11-13 | ||||||||
| 2022-06-30 | 11.13M shares 10-Q · filed 2023-08-11 | ||||||||
| 2022-03-31 | 12.85M shares 10-Q · filed 2023-05-12 | ||||||||
| 2021-12-31 | 5.64M shares 10-K · filed 2023-03-31 | ||||||||
| 2021-09-30 | 5.61M shares 10-Q · filed 2022-11-14 | 5.53M shares 10-Q · filed 2021-11-12 | |||||||
| 2021-06-30 | 5.44M shares 10-Q · filed 2022-08-11 | 5.33M shares 10-Q · filed 2021-08-12 | |||||||
| 2021-03-31 | 4.90M shares 10-Q · filed 2022-05-13 | ||||||||
| 2020-12-31 | 5.54M shares 10-K · filed 2022-03-30 | ||||||||
| 2020-09-30 | 5.55M shares 10-Q · filed 2020-11-12 | 5.51M shares 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | 6.69M shares 10-Q · filed 2020-08-14 | 6.63M shares 10-Q · filed 2021-08-12 | |||||||
| 2020-03-31 | 5.67M shares 10-Q · filed 2021-05-14 | ||||||||
| 2019-12-31 | 2.30M shares 10-K · filed 2021-03-30 | ||||||||
| 2019-09-30 | 2.30M shares 10-Q · filed 2020-11-12 | 2.30M shares 10-Q · filed 2019-11-13 | |||||||
| 2019-06-30 | 1.58M shares 10-Q · filed 2020-08-14 | 1.58M shares 10-Q · filed 2019-08-13 | |||||||
| 2019-03-31 | 1.62M shares 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | 2.24M shares 10-K · filed 2020-03-30 | ||||||||
| 2018-09-30 | 2.25M shares 10-Q · filed 2019-11-13 | 2.23M shares 10-Q · filed 2018-11-13 | |||||||
| 2018-06-30 | 1.92M shares 10-Q · filed 2019-08-13 | ||||||||
| 2018-03-31 | 1.75M shares 10-Q · filed 2019-05-14 | ||||||||
| 2017-12-31 | 6.39M shares 10-K · filed 2019-03-27 | ||||||||
| 2017-09-30 | 6.32M shares 10-Q · filed 2018-11-13 | ||||||||
| 2017-06-30 | 4.81M shares 10-Q · filed 2018-08-14 | ||||||||
| 2017-03-31 | 4.81M shares 10-Q · filed 2018-05-09 | ||||||||
| 2016-12-31 | 4.81M shares 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |